Marcel Dinger is Professor of Genome Biology and Dean of Science at the University of Sydney. He has 22 years' experience in genomics as both an academic and entrepreneur.

In addition to his research career, Marcel is co-founder of four start-ups in biotechnology and IT. He is a board director of Pryzm Health, a digital health enterprise focused on optimising patient care by empowering physicians with AI-based clinical decision support technology, and GenieUs, a genomics and machine-learning technology start-up dedicated to finding new therapies for neurodegenerative diseases.

He is President and Executive Committee Chair of the Australasian Genomics Technologies Association (AGTA), the principal body for the promotion of genomics research and technologies in Australasia.

Marcel served as Head of School of Biotechnology and Biomolecular Sciences at UNSW Sydney from 2019 to 2022 and is a former Director of the governance board of National Centre for Indigenous Genomics (NCIG), an ANU-based centre focused on using genomics to improve the health and well-being of Australia's First Peoples, and former Director of Scientia Clinical Research, a world-class clinical trials facility with a focus on early stage clinical research.